CircRARS that bind to IGF2BP3 in ccRCC promote ccRCC progression by maintaining the stability of downstream m6A-modified target molecules, such as CAPN15, CD44, HMGA2, TNRC6A, and ZMIZ2 [139]. The gene discussed is CD44; the disease is nonpapillary renal cell carcinoma.